Pelvic exenteration offers a survival benefit for advanced rectal cancer patients without distant spread. This study reports 54% 3-year and 37% 5-year survival rates after the procedure.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: